Vesper Healthcare Acquisition Corp. (VSPR)
|Net Income (ttm)||-1,540|
|Trading Day||January 25|
|Day's Range||10.97 - 11.20|
|52-Week Range||10.05 - 12.00|
The billionaire investor has been buying into the SPAC boom
Vesper Healthcare Acquisition agrees to acquire HydraFacial in a deal valued at up to $1.1 billion. The experiential beauty health company is looking to build a platform of services for medica...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Vesper Healthcare Acquisition Corp. Merger
WILMINGTON, Del., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Vesper Healthcare Acquisition Corp. (“Vesper”) (NASDAQ GS: VSPR) regarding possibl...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Vesper Healthcare Acquisition Corp. - VSPR
NEW YORK, Dec. 14, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in Ne...
HydraFacial CEO on SPAC merger: Vesper Healthcare comes with capital and a great reputation
This segment originally aired on December 9, 2020. Beauty Health Company HydraFacial is merging with Vesper Healthcare in a $1.1B SPAC deal.
NEW YORK, Dec. 10, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vesper Healthcare Acquisition...
Hydrafacial to go public in $1.1B SPAC deal led by Brent Saunders
Vesper Healthcare chairman Brent Saunders and Clint Carnell, CEO of Hydrafacial, join "Squawk on the Street" to discuss the deal to take Hydrafacial public via SPAC.
Vesper Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing November 20, 2020
MIAMI BEACH, Fla., Nov. 19, 2020 /PRNewswire/ -- Vesper Healthcare Acquisition Corp. (NASDAQ: VSPRU) (the "Company") announced that, commencing November 20, 2020, holders of the units sold in ...
Vesper Healthcare CEO: Didn't Intent to Do SPAC
Oct.05 -- Vesper Heathcare Chief Executive Officer Brent Saunders discusses the outlook for an effective Covid-19 vaccine, and his intentions for his new blank-check firm. He speaks on "Bloomb...
Vesper Healthcare Acquisition Corp. Announces Closing and Full Exercise of Underwriters' Over-Allotment Option
MIAMI BEACH, Fla., Oct. 2, 2020 /PRNewswire/ -- Vesper Healthcare Acquisition Corp. (NASDAQ:VSPRU) today announced the completion of its initial public offering of 46 million units at a price ...
Vesper Healthcare CEO discusses its decision to go public via SPAC
Vesper Healthcare Acquisition Corp. made its market debut on Sept. 30., pricing its initial public offering of 40 million units at $10.00 per unit. Former Allergan CEO Brent Saunders joins 'Cl...
Brent Saunders, former Chairman and CEO of Allergan, is co-founder, CEO, President and Chairman of Vesper Healthcare
Vesper Healthcare Acquisition is a newly incorporated blank check company incorporated in July 2020 as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While we may pursue an acquisition opportunity in any industry or sector, we intend to focus on the pharmaceuticals and healthcare sectors with an emphasis on companies in the medical aesthetics, eye care, longevity and wellness categories. Ou... [Read more...]
|IPO Date |
Sep 30, 2020
Brenton L. Saunders J.D.
|Stock Exchange |
|Ticker Symbol |